UW9-19977-01076
4 vaccinations
11 coded responses
28 check-ins
11 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 928 / CA
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
-
2021-01-14
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fever · Joint pains, Muscle or body achesFree text: Lymphadenopathy L axillary and L cervicalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · HeadacheFree text: Lymphadenopathy L cervical L axillary and L supraclavicularMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-18
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Lymphadenopathy L cervical, L supraclavicular, L axillaryMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-20
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: L cervical LADMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-21
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: L cervical lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-02-25
- 2021-04-17
-
2021-07-15
Survey response — 6 months, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Submandibular lymphadenopathyMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-09-26
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen lymph nodes on side of injectionMedDRA releases: 2024-11 · check-in free text available
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tirednessFree text: Swollen lymph nodes on same side as vaccineMedDRA releases: 2024-11 · check-in free text available
- 2021-10-01
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improved lymph node swellingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-13
- 2021-10-17
- 2021-10-24
- 2021-10-31
- 2021-11-07
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Upper respiratory tract infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: URI for 5 daysMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-29
-
2022-03-27
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Developed Covid infection at end of jan into feb. All symptoms resolved.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-28
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-10-07
- 2022-10-12
- 2022-10-28
- 2023-03-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-14 | Pfizer-BioNTech | |
| 3 | 2021-09-26 | Pfizer-BioNTech | No |
| 4 | 2022-09-28 | Pfizer-BioNTech | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-28 | Unsuccessful |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): Lymphadenopathy L axillary and L cervical
Systemic reaction (other): Lymphadenopathy L cervical L axillary and L supraclavicular
Systemic reaction (other): Lymphadenopathy L cervical, L supraclavicular, L axillary
Systemic reaction (other): L cervical LAD
Release 2 — day 7, dose 2
Systemic reaction (other): L cervical lymphadenopathy
Release 9 — 6 months, dose 2
Symptoms: Submandibular lymphadenopathy
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen lymph nodes on side of injection
Systemic reaction (other): Swollen lymph nodes on same side as vaccine
Systemic reaction (other): Improved lymph node swelling
Release 10 — 3 months, dose 3
Symptoms: URI for 5 days
Release 11 — 6 months, dose 3
Symptoms: Developed Covid infection at end of jan into feb. All symptoms resolved.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Lymphadenopathy | ✓ | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release